Sequential protein kinase reactions controlling cell growth and differentiation

G L Johnson1, R R Vaillancourt

  • 1Division of Basic Sciences, National Jewish Center for Immunology and Respiratory Medicine, Denver, CO 80206.

Insights

Growth factor receptor tyrosine kinase regulation of the mitogen-activated protein kinase (MAPK) pathway involves sequential protein kinase reactions. Key discoveries identified Raf-1 as a Ras GTP effector, advancing understanding of this critical cell signaling pathway.

Area of Science:

  • Cellular signaling and molecular biology
  • Signal transduction pathways

Background:

  • Protein kinase cascades are crucial for cellular communication.
  • The mitogen-activated protein kinase (MAPK) pathway is a central signaling cascade.
  • Understanding receptor tyrosine kinase (RTK) regulation of MAPK is vital for cell biology.

Purpose of the Study:

  • To elucidate the mechanisms of growth factor receptor tyrosine kinase regulation of the MAPK pathway.
  • To detail the sequential protein kinase reactions within the MAPK pathway.
  • To define the role of Ras GTP in mediating RTK signals to downstream kinases.

Main Methods:

  • Review and synthesis of published research on RTK-MAPK signaling.
  • Analysis of protein kinase interactions and phosphorylation events.
  • Identification of key signaling molecules and their regulatory roles.

Main Results:

  • Established the 1993 model for RTK regulation of the MAPK pathway.
  • Demonstrated sequential phosphorylation and activation of kinases in the pathway.
  • Identified Ras GTP as a key mediator linking RTKs to Raf-1.
  • Characterized Raf-1 as a serine-threonine protein kinase and an effector for Ras GTP.

Conclusions:

  • The MAPK pathway operates through a series of sequential protein kinase activations.
  • RTK signaling converges on Ras GTP, which then activates downstream components like Raf-1.
  • These findings provided a foundational understanding of a critical cell growth and differentiation pathway.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...